SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001855763-24-000014
Filing Date
2024-09-05
Accepted
2024-09-05 13:09:38
Documents
1
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2850
  Complete submission text file 0001855763-24-000014.txt   4475
Mailing Address C/O LUCID, INC. 50 METHODIST HILL DR, SUITE 1000 ROCHESTER NY 14623
Business Address
CHRISTOPHER RICHARD (Reporting) CIK: 0001271244 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39874 | Film No.: 241280790

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)